Fundz
Real-time · AI · Cross-signal

Voyager Biomedical just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on Voyager Biomedical, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Voyager Biomedical announced it raised $5.8 Million in an initial filing from an offering of $9.8 Million

PRIVATEApr 04, 2025•about 1 year ago

Amount Raised

$5.8 Million

HoustonHealthcareHealth Care

Company Information

Company

Voyager Biomedical

Location

114 HOLMES ROAD

Houston, Texas, United States

About

Voyager Biomedical is committed to improving the lives of dialysis patients by developing a novel vascular access device known as the VenaSure. The VenaSure has been designed to facilitate targeted needle placement and strengthen the vein by serving as a supportive exoskeleton. In addition, the VenaSure will increase patient comfort, reduce stress, and increase caregiver efficiency while benefiting the payer system by decreasing the surgeries necessary to enable long-term vascular access.

Related People

Suggested for you
2 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Voyager Biomedical's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Voyager Biomedical? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan